Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Toxicol Environ Chem. 2010 Oct;92(9):1673–1695. doi: 10.1080/02772241003711274

TABLE 4.

Correlation of MT-3 immunostaining with disease outcome.

MT-3 Negative MT-3 Positive Total

No progression (Alive, NED* or Died, NED) 15 75 90
Progression of Breast Cancer (Died, Breast Ca or Alive with Disease) 5 84 89

20 159 179
*

No Evidence of Disease